Vikas Lifecare share price target: 2024, 2025, 2026, 2028, 2030

Vikas Lifecare share price target

We are here to predict the share price of Vikas Lifecare for the years 2024-2030. The share price target is based on our research such as its financial results, revenue growth, debt ratio, profitability, past records market trends and many more.

If we look at the past, the company has not been able to show anything special in the last few years. There has not been any significant jump in the share price in the last three years.

Yes, once it touched the top line of Rs 20.64 in August 2020 and then later it has seen a decline. But, the company showed revenue growth of 15.12 per cent YoY and profit and profit margin negative in March 2023.

The market cap is Rs 446 crore, the PE ratio is 1.37 and the debt-to-equity ratio is 0.09 or 9 per cent. However, the company has expanded its business in recent years to various sectors which can also help in generating revenue and profit.

Vikas lifecare share price chart

Overview of Vikas Lifecare Limited

Vikas Lifecare is a pharmaceutical company engaged in the healthcare sector. Its focus is on innovation and quality which will help to grow in the coming years.

Product Portfolio

Vikas Lifecare’s diversified product portfolio covers a wide range of therapeutic segments including cardiovascular, neurology, gastroenterology and dermatology. The company’s commitment to research and development ensures a steady flow of new product launches, expanding its market reach and boosting investor confidence.

Fundamentals of Vikas Lifecare

Investing in the stock market requires careful analysis and foresight. Vikas Lifecare is one such company that has shown an average growth potential over the years.

Vikas Lifecare share price target for 2024-2030

The share price of the company has shown promising growth in the short term. Analysts have forecast a positive outlook for Vikas Lifecare and expect sustained growth and expansion in the coming months.

Vikas Lifecare is poised to tap new market opportunities and generate substantial returns for its shareholders. The target share price is expected to rise, making Vikas Lifecare an attractive investment option for those seeking short-term profitability in the pharmaceutical sector.

Therefore, based on the above factors, let us explore the possible share price targets for Vikas Lifecare over the next few years:

Related: MPS Infotecnics share price target


The company is focused on diversifying its product portfolio over the next 12 months. Which will help the company to grow and generate revenue and profit. So, based on our research and market experts, Vikas Lifecare’s share price will reach Rs 6.50 to Rs 9.20 by the end of 2024.


Vikas Lifecare has demonstrated consistent positive financial growth over the years due to growth in revenue and efficient cost management. With positive industry trends and market conditions, Vikas Lifecare’s share price may see further growth, potentially reaching Rs 10.30 to Rs 13.10 by the end of 2025.


The diversified product portfolio of the company is likely to have a positive impact on the share price. By 2026, Vikas Lifecare’s share price is expected to steady growth in the middle of the year with a target range of Rs 11.20 to Rs 14.30.


The company has a good range of products including generic and specialty pharmaceuticals, which contribute to its revenue stream. Looking ahead, long-term growth looks a bit promising for Vikas Lifecare. Strong financial performance, successful product launches and a favourable industry outlook could propel the share price to Rs 15.00 to Rs 19.30 by 2028.


The global pharmaceutical industry is witnessing steady growth of a rising population, healthcare expenditure, and advancements in medical technology. As we move towards 2030, the share price of Vikas Lifecare can potentially reach Rs 19.10 to Rs 24.50. The share price depends on its ability to adapt to emerging market changes.

Risk Factors for Vikas Lifecare

There are many factors that can affect the share price of the company which are mentioned below:

  • Market Condition: Market conditions determine the share price of any company, such as economic stability and investor sentiment can affect the demand for a stock.
  • Regulatory and Compliance Risk: Generally, pharmaceutical companies operate in a highly regulated environment, if it goes to the contrary it can impact revenue growth and profits.
  • Drug Pricing and Reimbursement: Changes in healthcare policies and government regulations can have a significant impact on pharmaceutical companies’ pricing strategies and profitability.
Is Vikas Lifecare a good buy for the long term?

Looking at the past, the financial results of Vikas Lifecare have been below average and you cannot expect good returns in the long term.

What is the target price of Vikas Lifecare shares in 2025?

Vikas Lifecare’s share price may see further upside and the maximum expected price is Rs 10.30 to Rs 13.10 by the end of 2025.

Is Vikas Lifecare debt free?

Vikas Lifecare has a debt ratio of 0.09 or 9 per cent, which is almost debt free.

What is the old name of Vikas Lifecare?

The old name of Vikas Lifecare is Vikas Multicorp Limited, which changed to Vikas Lifecare in April 2021.

What is the target price of Vikas Lifecare share in 2030?

The share price of Vikas Lifecare can potentially reach Rs 19.10 to Rs 24.50 in 2030.


The share price target is based on our research and technical analysis, which may not be accurate by any means. Overall, Vikas Lifecare has shown a consistently stable performance over the past few years and cannot expect an upside in the next few years. But, the stock market is uncertain and what will happen depends on the situation at that time.


See also:

(Disclaimer: Vikas Lifecare’s share price target is for general information only. We are not SEBI-registered financial advisors and no part of the website content should be considered financial advice. Before investing do your own research and consult your financial advisor).

About Bankshala team

We are a dedicated professional team, working closely with each other to provide quality content in the banking and finance sectors. Some editors have been investing in the stock market for almost 15 years and have a lot of experience.

View all posts by Bankshala team

Leave a Reply

Your email address will not be published. Required fields are marked *